These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3174740)

  • 1. Dissociation of the opioid and nonopioid effects of cyclazocine.
    Calligaro D; Young GA; Khazan N
    Pharmacol Biochem Behav; 1988 May; 30(1):163-7. PubMed ID: 3174740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM; Devia C; Brocklehurst C
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of serotonin in the behavioral changes induced in the rat by cyclazocine].
    Gavend MR; Serre-Debeauvais F; Gavend M
    J Pharmacol; 1986; 17(4):601-14. PubMed ID: 3560971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of cyclazocine in the rat.
    Teal JJ; Holtzman SG
    J Pharmacol Exp Ther; 1980 Mar; 212(3):368-76. PubMed ID: 7359340
    [No Abstract]   [Full Text] [Related]  

  • 5. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
    Gilbert PE; Martin WR
    J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced sensitivity to behavioral effects of naltrexone in rats.
    Schindler CW; Wu XZ; Su TP; Goldberg SR; Katz JL
    J Pharmacol Exp Ther; 1990 Jan; 252(1):8-14. PubMed ID: 2405152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey.
    Teal JJ; Holtzman SG
    J Pharmacol Exp Ther; 1980 Nov; 215(2):369-76. PubMed ID: 7441501
    [No Abstract]   [Full Text] [Related]  

  • 9. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
    White DA; Hwang ML; Holtzman SG
    Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties.
    Tang AH; Franklin SR
    Pharmacol Biochem Behav; 1983 Jun; 18(6):873-7. PubMed ID: 6889416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-like discriminative stimulus effects of the stereoisomers of alpha- and beta-cyclazocine in rats.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1988 Feb; 244(2):606-12. PubMed ID: 3346838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulus properties of opioids with mixed agonist and antagonist activity.
    Holtzman SG
    Fed Proc; 1982 May; 41(7):2328-32. PubMed ID: 6281084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations on the antagonistic actions of opioid antagonists.
    Young AM; Woods JH
    Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D; Harris RA
    Psychopharmacology (Berl); 1982; 76(2):177-81. PubMed ID: 6281840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.